Berkshire's Q2 stumble underscores the challenges ahead as Buffett's succession nears amid market turbulence and shifting ...

Stocks fell sharply Friday as investors responded to President Donald Trump's latest moves on tariffs and an employment ...

Colgate-Palmolive (NYSE: CL ) stock gave up gains as the consumer products giant reported better-than-expected second quarter results, while Kimberly-Clark (NASDAQ: KMB ) gained after its ...

Social media platform Snap ($SNAP) is scheduled to announce its results for the second quarter of 2025 on August 5. SNAP stock is significantly ...

Verizon customers with select legacy plans have had free access to Apple Arcade, but Verizon is ending support for the ...

Apple CEO Tim Cook made it clear that Apple is growing its AI investments, both in infrastructure and personnel, and multiple ...

Apple's Q3/25 results show strong performance, but concerns grow over iPhone sales plateauing, tariff headwinds, and AI ...

JPMorgan analyst Samik Chatterjee maintained an Overweight rating on Apple and raised the price target from $250 to $255.

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge.

For more market updates plus actionable trade ideas for stocks, options and crypto, subscribe to MarketDiem by Investor's Business Daily. This content was created by MarketWatch, which is operated by ...

Pharma giant Moderna Inc (NASDAQ:MRNA) is off 7% ahead of the open, following the company's smaller-than-anticipated ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...